Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Amprius Technologies | AMPX | Jan 14, 2025 | 3.41 | +4.92 |
AMREP | AXR | Jan 14, 2025 | 29.79 | +2.55 |
AMTD Digital ADR | HKD | Jan 14, 2025 | 2.65 | +2.32 |
AMTD Idea Group ADR | AMTD | Jan 14, 2025 | 1.07 | +7.00 |
Amtech Systems | ASYS | Jan 14, 2025 | 5.31 | -2.21 |
Amylyx Pharmaceuticals | AMLX | Jan 14, 2025 | 3.13 | -1.57 |
AN2 Therapeutics | ANTX | Jan 14, 2025 | 1.22 | -3.17 |
Analog Devices | ADI | Jan 14, 2025 | 214.65 | +0.80 |
AnaptysBio | ANAB | Jan 14, 2025 | 14.91 | +1.98 |
Anavex Life Sciences | AVXL | Jan 14, 2025 | 10.47 | -0.76 |
Andretti Acquisition II | POLE | Jan 14, 2025 | 10.03 | 0.00 |
Andretti Acquisition II Unit | POLEU | Jan 14, 2025 | 10.07 | 0.00 |
Anebulo Pharmaceuticals | ANEB | Jan 14, 2025 | 1.60 | +5.66 |
Angel Oak Financial Strategies | FINS | Jan 14, 2025 | 13.18 | +0.61 |
Angel Oak Mortgage REIT | AOMR | Jan 14, 2025 | 9.62 | +1.16 |
Anghami | ANGH | Jan 14, 2025 | 0.75 | +20.58 |
Angi A | ANGI | Jan 14, 2025 | 1.70 | +8.97 |
AngioDynamics | ANGO | Jan 14, 2025 | 11.80 | -5.30 |
Anglogold Ashanti | AU | Jan 14, 2025 | 26.40 | +3.77 |
Anheuser-Busch InBev ADR | BUD | Jan 14, 2025 | 46.49 | +0.17 |
ANI Pharmaceuticals | ANIP | Jan 14, 2025 | 54.16 | +0.43 |
Anika Therapeutics | ANIK | Jan 14, 2025 | 15.58 | -2.14 |
Anixa Biosciences | ANIX | Jan 14, 2025 | 2.13 | -2.74 |
Annaly Capital Management | NLY | Jan 14, 2025 | 18.39 | +1.49 |
Annaly Capital Management F Pref | NLY-F | Jan 14, 2025 | 25.50 | +0.51 |
Annaly Capital Management G Pref | NLY-G | Jan 14, 2025 | 25.35 | +0.08 |
Annaly Capital Management I Pref | NLY-I | Jan 14, 2025 | 25.47 | +0.43 |
Annexon | ANNX | Jan 14, 2025 | 4.53 | -8.30 |
Annovis Bio | ANVS | Jan 14, 2025 | 4.67 | -2.10 |
ANSYS | ANSS | Jan 14, 2025 | 339.58 | +0.71 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.